| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/27/2003 | US20030040022 Dopamine receptors and genes |
| 02/27/2003 | US20030040014 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030040013 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030040012 Method of detecting protein-protein interaction |
| 02/27/2003 | US20030040007 Human BMP-7 promoter and method for exploring bone-related substance by using the same |
| 02/27/2003 | US20030040001 LETM1: modulators of cellular proliferation |
| 02/27/2003 | US20030039999 B7 related protein-2 molecules and uses thereof |
| 02/27/2003 | US20030039995 YS68 gene involved in primitive hematopoiesis |
| 02/27/2003 | US20030039994 Nucleotide sequences coding polypeptide for use in the treatment diagnosis and prevention of cancer |
| 02/27/2003 | US20030039993 Nucleotide sequences coding polypeptide for use in the treatment diagnosis and prevention of cancer |
| 02/27/2003 | US20030039988 Nucleotide sequences for use as tools in genetic engineering |
| 02/27/2003 | US20030039987 Defects in periaxin associated with myelinopathies |
| 02/27/2003 | US20030039984 Sequences upstream of the CARP gene, vectors containing them and uses thereof |
| 02/27/2003 | US20030039983 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer |
| 02/27/2003 | US20030039982 Nucleotide sequences coding polypeptide for use in the diagnosis treatment and prevention of tumors |
| 02/27/2003 | US20030039981 Probes for use as diagnostic tools in the detection of parasites |
| 02/27/2003 | US20030039974 One step sample preparation and detection of nucleic acids in complex biological samples |
| 02/27/2003 | US20030039972 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030039971 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment and prevention of cancer, skin, vascular, kidney and inflammatory disorders |
| 02/27/2003 | US20030039970 Diagnosing cancer in humans; obtain tissue sample, determine concentration of calreticulin in sample, compare to control, evaluate for cancer |
| 02/27/2003 | US20030039969 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030039968 Peptide for use in the treatment of cell proliferative and nervous system disorders |
| 02/27/2003 | US20030039966 Genetic engineering; bone disorders |
| 02/27/2003 | US20030039962 Therapy, medical diagnosis, drug |
| 02/27/2003 | US20030039959 Detection of premature tumor cells in mammary gland tissue; obtain mammary gland tissue, incubate with diagnostic agent, monitor sample for binding and signal, presence of signal indicates premature cancer |
| 02/27/2003 | US20030039955 Compositions and methods for production of RNA viruses and RNA virus-based vector particles |
| 02/27/2003 | US20030039954 Viral nucleotide sequences for use in the diagnosis, prevention and treatment of viral diseases |
| 02/27/2003 | US20030039664 Isolated nucleotide sequences associated with multiple sclerosis or rheumatoid arthritis and a process of detecting |
| 02/27/2003 | US20030039663 Vaccine; neutralizing antibodies; detecting infections |
| 02/27/2003 | US20030039660 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 02/27/2003 | US20030039658 Probes for leukemia-associated translocation junctions and to identifv reagents promoting dissociation of those proteins from each other or inhibiting their association and to discover anti-HIV reagents |
| 02/27/2003 | US20030039655 Novel engineered superantigen for human therapy |
| 02/27/2003 | US20030039654 Amino acid sequence of parathyroid hormone/parathyroid hormone related protein modulating domains and a vehicle for to stimulate renal calcium reabsorption |
| 02/27/2003 | US20030039647 Tetraspan protein and uses thereof |
| 02/27/2003 | US20030039646 Receptor interacting protein, which binds to itself and to other intracellular modulatory proteins; treating tumor cells or HIV-infected cells |
| 02/27/2003 | US20030039641 Cells expressing anti-fc receptor binding components |
| 02/27/2003 | US20030039640 Infecting cells with a retrovirus in the presence of an immobilized material including a ligand which bings to the cell and a ligand which binds to the retrovirus |
| 02/27/2003 | US20030039639 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 02/27/2003 | US20030039635 Compositions and methods for WT1 specific immunotherapy |
| 02/27/2003 | US20030039632 Novel bacteriocins, transport and vector system and method of use thereof |
| 02/27/2003 | US20030039631 Adenovirus p53 compositions and methods |
| 02/27/2003 | US20030039505 Document folder |
| 02/27/2003 | US20030038828 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030038827 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030038826 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | CA2458648A1 Secreted proteins |
| 02/27/2003 | CA2458643A1 Nucleic-acid associated proteins |
| 02/27/2003 | CA2458625A1 Transporters and ion channels |
| 02/27/2003 | CA2458193A1 Development of transgenic model for interventions in neurodegenerative diseases |
| 02/27/2003 | CA2457932A1 Sodium channel regulators and modulators |
| 02/27/2003 | CA2457805A1 Bovine leptin protein, antisense and antibody |
| 02/27/2003 | CA2457781A1 Kgf polypeptide compositions |
| 02/27/2003 | CA2457496A1 Gpcr-like retinoic acid-induced gene 1 protein and nucleic acid |
| 02/27/2003 | CA2457321A1 Combinatorial methods for inducing cancer cell death |
| 02/27/2003 | CA2457317A1 Transgenic rodents as animal models for modulation of b1 bradykinin receptor protein |
| 02/27/2003 | CA2457301A1 Porcine leptin protein, antisense and antibody |
| 02/27/2003 | CA2457298A1 Novel human collagen proteins and polynucleotides encoding the same |
| 02/27/2003 | CA2457288A1 Excitatory glycine receptors and methods |
| 02/27/2003 | CA2457226A1 Nucleic acids and proteins of insect or83b odorant receptor genes and uses thereof |
| 02/27/2003 | CA2457164A1 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells |
| 02/27/2003 | CA2457163A1 Derp1 and proderp1 allergen derivatives |
| 02/27/2003 | CA2457143A1 In situ immunization |
| 02/27/2003 | CA2457102A1 Computer-based methods of designing molecules |
| 02/27/2003 | CA2457095A1 Zinc finger domain libraries |
| 02/27/2003 | CA2457066A1 Human protooncogene kg-20 and protein encoded therein |
| 02/27/2003 | CA2457065A1 Periostin-based diagnostic assays |
| 02/27/2003 | CA2457060A1 New biopesticide using gene from erwinia pyrifoliaewt#3, novel pathogen that affects asian pear trees |
| 02/27/2003 | CA2457008A1 Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease |
| 02/27/2003 | CA2456966A1 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 02/27/2003 | CA2456843A1 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine |
| 02/27/2003 | CA2456753A1 Mammalian relaxin receptors |
| 02/27/2003 | CA2456470A1 Interleukin-2 mutants with reduced toxicity |
| 02/27/2003 | CA2456340A1 Propagation of human hepatoblastoma cell in non-human animals |
| 02/27/2003 | CA2456158A1 Anti-aging and wound healing compounds |
| 02/27/2003 | CA2455974A1 Methods for purification of an activated peg solution and for the synthesis of a modified hemoglobin solution |
| 02/27/2003 | CA2454879A1 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma |
| 02/27/2003 | CA2454860A1 Hybrid interferon/interferon tau proteins, compositions and methods of use |
| 02/27/2003 | CA2454853A1 Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier |
| 02/27/2003 | CA2454756A1 Methods and compounds for the targeting of protein to exosomes |
| 02/27/2003 | CA2446848A1 Derivatives of magainin |
| 02/26/2003 | EP1286163A2 Evaluation of agents for treatment of Schizophrenia |
| 02/26/2003 | EP1285971A2 Methods for the phenotypic and genotypic assessment of the drug sensitivity of HIV integrase variants |
| 02/26/2003 | EP1285967A2 Human retroviral packaging cell line |
| 02/26/2003 | EP1285965A1 Bifactorial endosperm box, trans-activating factor that binds thereto, and method of regulation of promoter activity |
| 02/26/2003 | EP1285964A2 Human Mater proteins |
| 02/26/2003 | EP1285960A2 Virulence genes from Salmonella typhimurium |
| 02/26/2003 | EP1285942A1 Polypeptide derivatives and nucleic acid carriers containing the same |
| 02/26/2003 | EP1285929A1 96895, A human sodium-hydrogen exchanger family member and uses therefor |
| 02/26/2003 | EP1285666A1 Salmonella typhi vaccine compositions |
| 02/26/2003 | EP1285664A2 Methods of increasing lean tissue mass using OB protein compositions |
| 02/26/2003 | EP1285578A2 Transgenic animal model of Alzheimer's disease |
| 02/26/2003 | EP1285272A2 Compositions and methods for screening therapeutic agents |
| 02/26/2003 | EP1285269A2 Lipid uptake assays |
| 02/26/2003 | EP1285087A2 Enzymatic assays for screening anti-cancer agents |
| 02/26/2003 | EP1285077A2 Triacylglycerol lipases from arabidopsis thaliana |
| 02/26/2003 | EP1285076A2 Production of silk-like proteins in plants |
| 02/26/2003 | EP1285075A1 Process for the fermentative preparation of l-threonine |
| 02/26/2003 | EP1285072A2 In vitro fucosylation recombinant glycopeptides |
| 02/26/2003 | EP1285071A2 Novel dual oxidases as mitogenic and endocrine regulators |
| 02/26/2003 | EP1285069A1 Anti-listeria bacteriocin |